Skip to content

The people behind it

Deeply connected to this industry, and invested in the people running it.

Intake AI is three co-founders who came to clinical research through the people it touched, and who have spent time on the inside of it — coordinating visits, chasing documents, doing the work this software now does.

The Intake AI founding team
Samir Hooker, Lakshman Peri and Miles Wingfield

Our mission

Every one of us came to clinical research through someone we love. That is where this started, and it is still the reason we are here.

We have worked inside research sites — coordinating visits, chasing documents down, building by hand the paperwork this software now writes. We know which parts of a day disappear and where they go, because we lost them too.

The people running these sites are extraordinary. They hold trials together through systems that were never designed for them, and they do it because someone is waiting at the other end of the study. Our whole job is to make that lighter — and we judge everything we build by whether it would have helped us on a Tuesday afternoon with four visits still to document.

We are on your side of the table.

We are also committed to this reaching further. Clinical research works best in the communities that already have access to it, and we want to help change that — so that a site serving an underserved community can run a trial without drowning in work that has nothing to do with patients.

The team

Tap a photo for the full profile

  • Samir Hooker

    Co-Founder & CEO

    A San Francisco native and UC Berkeley graduate who gravitated to clinical research after watching his single mother battle a number of autoimmune diseases with a lack of medications that actually worked.

    He is a repeat founder whose prior company, VitifyHealth, used AI to match patients to trials. He is now co-founder and CEO of Intake AI, where he builds AI agents that run the operational workflows pharmaceutical companies employ their clinical research sites to do by hand today.

    He designs the product alongside coordinators and site networks, against how trials actually operate rather than how protocols describe them. He believes the bottleneck in drug development is operations, not biology.

    LinkedIn
    LinkedIn
  • Miles Wingfield

    Co-Founder & COO

    A UC Berkeley public health graduate who came to clinical research by way of tuberculosis research and EKG tech work.

    He has led business development for research sites, advises the CRO DiversiTrials, and leads AI programming on the WCG MAGI steering committee. He speaks regularly at prominent clinical research conferences across the industry.

    He is a vocal advocate for health equity and for widening access to life-saving trials.

    LinkedIn
    LinkedIn
  • Lakshman Peri

    Co-Founder & CTO

    Has been working at the intersection of technology and healthcare since high school, when he first began building robotics solutions to address public health problems.

    He’s a graduate of UC Berkeley, and a published researcher with experience at both Berkeley AI Research and the Tata Institute of Fundamental Research.

    Now, as Co-Founder and CTO of Intake AI, he’s building technology that makes clinical trials more effective and their outcomes more reliable.

    LinkedIn
    LinkedIn

Join the team

Come and move drug development forward.

We are three people, and the work we do lands a long way from this office — on a coordinator's afternoon, on whether a trial can run somewhere it currently cannot, and eventually on someone getting a treatment sooner. We are looking for the next few people who want that to be what their week adds up to.

  • Sales
  • Marketing
  • Engineering
  • Clinical operations
  • + more

Come and see what we have built.